Free Trial

Alliance Pharma (APH) Competitors

Alliance Pharma logo
GBX 64.60 +0.10 (+0.16%)
As of 07:21 AM Eastern

APH vs. SPI, ESP, RTN, IPF, SGM, MSI, MCP, BERI, AMAT, and STM

Should you be buying Alliance Pharma stock or one of its competitors? The main competitors of Alliance Pharma include Spire Healthcare Group (SPI), Empiric Student Property (ESP), The Restaurant Group (RTN), International Personal Finance (IPF), Sigma Capital Group (SGM), MS INTERNATIONAL (MSI), Martin Currie Asia Unconstrand Trust (MCP), BlackRock Energy and Resources (BERI), Amati AIM VCT (AMAT), and STM Group (STM). These companies are all part of the "electronic equipment" industry.

Alliance Pharma vs.

Alliance Pharma (LON:APH) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, community ranking, risk, profitability, media sentiment and institutional ownership.

Spire Healthcare Group has higher revenue and earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alliance Pharma£183.50M1.91-£33.65M-£6.20-10.41
Spire Healthcare Group£1.44B0.55£28.15M£7.0327.95

Spire Healthcare Group has a net margin of 1.96% compared to Alliance Pharma's net margin of -18.34%. Spire Healthcare Group's return on equity of 3.82% beat Alliance Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Alliance Pharma-18.34% -15.24% 5.98%
Spire Healthcare Group 1.96%3.82%3.73%

Alliance Pharma has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, Spire Healthcare Group has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Alliance Pharma presently has a consensus price target of GBX 6,250, suggesting a potential upside of 9,574.92%. Spire Healthcare Group has a consensus price target of GBX 300, suggesting a potential upside of 52.75%. Given Alliance Pharma's higher probable upside, equities research analysts clearly believe Alliance Pharma is more favorable than Spire Healthcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alliance Pharma
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 3.1%. Spire Healthcare Group pays an annual dividend of GBX 3 per share and has a dividend yield of 1.5%. Alliance Pharma pays out -32.2% of its earnings in the form of a dividend. Spire Healthcare Group pays out 42.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.

66.3% of Alliance Pharma shares are owned by institutional investors. Comparatively, 50.4% of Spire Healthcare Group shares are owned by institutional investors. 12.0% of Alliance Pharma shares are owned by company insiders. Comparatively, 34.7% of Spire Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Spire Healthcare Group had 4 more articles in the media than Alliance Pharma. MarketBeat recorded 4 mentions for Spire Healthcare Group and 0 mentions for Alliance Pharma. Spire Healthcare Group's average media sentiment score of 0.62 beat Alliance Pharma's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Alliance Pharma Neutral
Spire Healthcare Group Positive

Spire Healthcare Group received 153 more outperform votes than Alliance Pharma when rated by MarketBeat users. However, 61.89% of users gave Alliance Pharma an outperform vote while only 60.96% of users gave Spire Healthcare Group an outperform vote.

CompanyUnderperformOutperform
Alliance PharmaOutperform Votes
203
61.89%
Underperform Votes
125
38.11%
Spire Healthcare GroupOutperform Votes
356
60.96%
Underperform Votes
228
39.04%

Summary

Spire Healthcare Group beats Alliance Pharma on 13 of the 20 factors compared between the two stocks.

Get Alliance Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APH vs. The Competition

MetricAlliance PharmaDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£349.77M£2.17B£5.54B£2.58B
Dividend Yield3.75%2.92%5.09%4.97%
P/E Ratio-10.413.9522.60133.24
Price / Sales1.91505.10400.01232,001.44
Price / Cash7.8710.2538.1828.14
Price / Book1.576.606.774.59
Net Income-£33.65M£20.70B£3.22B£5.84B
7 Day PerformanceN/A0.74%1.10%3.02%
1 Month Performance0.62%1.55%2.48%10.16%
1 Year Performance91.69%91.84%15.71%117.48%

Alliance Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APH
Alliance Pharma
2.0749 of 5 stars
GBX 64.60
+0.2%
GBX 6,250
+9,574.9%
+89.7%£349.77M£183.50M-10.4191,000
SPI
Spire Healthcare Group
2.1754 of 5 stars
GBX 182.60
-1.5%
GBX 300
+64.3%
-21.0%£733.27M£1.44B25.99420
ESP
Empiric Student Property
N/AGBX 90.40
+0.2%
N/A+1.7%£598.82M£89.58M10.15150Positive News
RTN
The Restaurant Group
N/AN/AN/AN/A£499.23M£927M-1,080.0064,000
IPF
International Personal Finance
N/AGBX 134.40
+0.6%
N/A+37.8%£292.08M£695.42M6.516,230Analyst Forecast
News Coverage
SGM
Sigma Capital Group
N/AN/AN/AN/A£181.35M£10.60M54.5948,300
MSI
MS INTERNATIONAL
N/AGBX 924.20
+3.3%
N/A+7.6%£146.68M£107.14M12.88455
MCP
Martin Currie Asia Unconstrand Trust
N/AN/AN/AN/A£145.58M£6.14M43.1321,000
BERI
BlackRock Energy and Resources
N/AGBX 105
-0.5%
N/A-11.2%£124.54M£25.44M5.52N/APositive News
AMAT
Amati AIM VCT
N/AGBX 65
-0.8%
N/A-33.9%£95.42M£-5,647,748.73-8.9333,000Gap Down
STM
STM Group
N/AN/AN/AN/A£35.53M£30.06M3,075.0048,300

Related Companies and Tools


This page (LON:APH) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners